$6.28
In chiusura: Nov 6 EDT
$6.28
0.000.00%
Pre-mercato: 7:47 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Capricor Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 10
Stima EPS
$-0.540
Stima dei ricavi trimestrali
$1.25M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$13.39M
Analizza lo storico degli utili di Capricor Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CAPR | Capricor Therapeutics | -$0.38 | -$0.54 | — | — | $2.26M | $1.25M | — | — | 11/10/2025 | |
CAPR | Capricor Therapeutics | -$0.35 | -$0.48 | -$0.57 | -18.75% | $3.97M | $1.62M | $0.00 | -100.00% | 08/11/2025 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.32 | -$0.53 | -65.62% | $4.91M | $3.16M | $0.00 | -100.00% | 05/13/2025 | |
CAPR | Capricor Therapeutics | -$0.02 | -$0.31 | -$0.16 | 48.39% | $12.09M | $3.20M | $11.13M | 247.84% | 03/19/2025 | |
CAPR | Capricor Therapeutics | -$0.25 | -$0.36 | -$0.38 | -5.56% | $6.18M | $3.57M | $2.26M | -36.64% | 11/13/2024 | |
CAPR | Capricor Therapeutics | -$0.29 | -$0.36 | -$0.35 | 2.78% | $3.92M | $3.66M | $3.97M | 8.50% | 08/07/2024 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.11 | -$0.31 | -181.82% | $2.99M | $9.70M | $4.91M | -49.41% | 05/13/2024 | |
CAPR | Capricor Therapeutics | -$0.31 | -$0.09 | -$0.02 | 77.78% | $959.90K | $10.60M | $12.09M | 14.04% | 02/29/2024 | |
CAPR | Capricor Therapeutics | -$0.26 | -$0.29 | -$0.25 | 13.79% | $1.59M | $2.11M | $6.18M | 193.13% | 11/14/2023 | |
CAPR | Capricor Therapeutics | -$0.29 | -$0.35 | -$0.29 | 17.14% | $0.00 | $1.50M | $3.92M | 161.13% | 08/07/2023 | |
CAPR | Capricor Therapeutics | -$0.32 | -$0.32 | -$0.31 | 3.12% | $0.00 | $500.00K | $2.99M | 497.40% | 05/11/2023 | |
CAPR | Capricor Therapeutics | -$0.26 | -$0.33 | -$0.31 | 6.06% | $0.00 | — | $959.90K | — | 03/15/2023 | |
CAPR | Capricor Therapeutics | -$0.17 | -$0.29 | -$0.26 | 10.34% | $0.00 | $210.00K | $1.59M | 658.10% | 11/10/2022 | |
CAPR | Capricor Therapeutics | -$0.22 | — | -$0.29 | — | $204.08K | — | $0.00 | — | 08/10/2022 | |
CAPR | Capricor Therapeutics | -$0.23 | — | -$0.32 | — | $40.82K | — | $0.00 | — | 05/10/2022 | |
CAPR | Capricor Therapeutics | -$0.21 | -$0.19 | -$0.26 | -36.84% | $57.83K | — | $0.00 | — | 03/10/2022 | |
CAPR | Capricor Therapeutics | -$0.20 | -$0.22 | -$0.17 | 22.73% | $16.86K | $210.00K | $0.00 | -100.00% | 11/09/2021 | |
CAPR | Capricor Therapeutics | -$0.23 | -$0.23 | -$0.22 | 4.35% | $49.86K | $210.00K | $204.08K | -2.82% | 08/12/2021 | |
CAPR | Capricor Therapeutics | -$0.30 | — | -$0.23 | — | $185.69K | — | $40.82K | — | 05/13/2021 | |
CAPR | Capricor Therapeutics | -$0.34 | — | -$0.21 | — | $222.10K | $210.00K | $57.83K | -72.46% | 03/11/2021 | |
CAPR | Capricor Therapeutics | -$0.43 | -$0.37 | -$0.20 | 45.95% | $142.07K | $210.00K | $16.86K | -91.97% | 11/12/2020 |
Capricor Therapeutics (CAPR) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.57 | $-0.48 | -18.8 % |
| Q1 | 2025-05-13 | $-0.53 | $-0.32 | -65.6 % |
| Q4 | 2025-03-19 | $-0.16 | $-0.31 | 48.4 % |
| Q3 | 2024-11-13 | $-0.38 | $-0.36 | -5.56 % |
Capricor Therapeutics (CAPR) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $0 | $1.62M | -100.0 % |
| Q1 | 2025-05-13 | $0 | $3.16M | -100.0 % |
| Q4 | 2025-03-19 | $11.13M | $3.20M | 247.8 % |
| Q3 | 2024-11-13 | $2.26M | $3.57M | -36.6 % |
FAQ
Quando Capricor Therapeutics (NASDAQ:CAPR) riporterà gli utili?
Si prevede che Capricor Therapeutics (CAPR) fornisca risultati il novembre 10, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Capricor Therapeutics (NASDAQ:CAPR)?
L'EPS effettivo era $-0.57, che mancato la stima di $-0.48.
Quali sono state le entrate di Capricor Therapeutics (NASDAQ:CAPR)?
Le entrate effettive sono state $0K, che mancato la stima di $1.6M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.